<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20261028071589N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-21</date_registration>
      <primary_sponsor>Research Deputy of Bu-Ali Sina University, Hamedan</primary_sponsor>
      <public_title>Effect of dynamic neuromuscular stabilization exercise combined with neurofeedback and cognitive functional training on plantar pressure variables, brain electrical activity patterns, and lumbar muscle strength in men with chronic non-specific low back pain</public_title>
      <acronym></acronym>
      <scientific_title>Effect of dynamic neuromuscular stabilization exercise combined with neurofeedback and cognitive functional training on plantar pressure variables, brain electrical activity patterns, and lumbar muscle strength in men with chronic non-specific low back pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-11-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/94524</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization was by the lottery method. We write the control and experimental titles on papers and ask the subjects that each of them take one of them, Blinding description: Data analysts will not be informed of the group division (group information in the form of group 1 and 2 and 3 for each participant with a code will be provided to the analysts).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic Non-Specific Low Back Pain.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: The combined intervention (dynamic neuromuscular stabilization exercises integrated with neurofeedback) will be conducted over eight consecutive weeks, consisting of three sessions per week. Each session will last 75 to 80 minutes (comprising 45–50 minutes of dynamic neuromuscular stabilization exercises and 30 minutes of neurofeedback). The dynamic neuromuscular stabilization exercises include diaphragmatic breathing, the 90/90 supine position, prone positioning, rolling, side-sitting, oblique sitting, tripod positioning, kneeling, squatting, and rising to a standing position. Neurofeedback training will be conducted following dynamic neuromuscular stabilization exercises, utilizing an 8-channel ProComp Infiniti system paired with BioGraph software. Drawing upon established protocols for chronic pain, the neurofeedback protocol will focus on increasing the power of alpha waves (8–13 Hz) while suppressing beta (15–20 Hz) and theta (4–7 Hz) wave activity at the Cz site (the central region of the brain). The Cz site was selected due to its proximity to the sensorimotor cortex—an area that plays a vital role in postural control and pain processing. Intervention 2: Second Intervention group: The combined training program—consisting of dynamic neuromuscular stabilization exercises integrated with cognitive-functional exercises—will be conducted over eight consecutive weeks. This will involve three sessions per week, with each session comprising approximately 45 to 50 minutes of dynamic neuromuscular stabilization exercises, alongside a total of eighteen sessions (over the same eight-week period) of cognitive-functional exercises, each lasting 60 minutes. The dynamic neuromuscular stabilization exercises include diaphragmatic breathing, the 90/90 supine position, prone positioning, rolling initiation, side-sitting, oblique sitting, the tripod position, kneeling, squatting, and rising to a standing position. Cognitive-functional exercise sessions will be conducted on an individual basis in a quiet room. This protocol consists of three main components. The cognitive component focuses on identifying the primary factors contributing to pain—as determined during assessments—including the multidimensional nature of chronic pain, as well as the individual’s beliefs, emotions, and behaviors (e.g., movement patterns and lifestyle) that may exacerbate a "domino effect" of pain and disability. Patients will be educated on the biopsychosocial model of pain, and unhelpful beliefs will be addressed through cognitive restructuring. Functional Component: This component includes specific functional exercises designed to normalize movements and postures that are maladaptive or provocative. Patients are gradually exposed to activities they fear or avoid (controlled exposure), ensuring they feel secure while engaging in painful activities or resting their bodies. Lifestyle Component: This component integrates functional activities into daily living tasks, such as bending, sitting, standing, and lying down. Gradual exposure to everyday activities, combined with fear-reduction strategies, is implemented to foster long-term behavioral change. Intervention 3: Control group: At the beginning of the study, all assessments will be administered to the individuals in the control group. These participants will not take part in any rehabilitation interventions; instead, they will continue with their normal, routine lives and daily activities throughout the 8-week period. Following these 8 weeks, a post-test will be conducted.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data files containing measurements taken by the testers will be shared after the study concludes, if necessary.

When:
The course begins one year after the publication of the results and articles.

To whom:
Researchers and scholars whose field of work aligns with the present study and who are employed at universities.

Conditions:
The data from the present study will be made available to other researchers solely for the purpose of comparison with future studies; any use or analysis of these data is unauthorized.

Where to obtain:
Email address: abolfazlborzouab1377@gmail.com

How to obtain:
If the applicant provides documentation demonstrating relevance to their field of work in relation to the thesis topic, and upon a reasonable request and commitment not to misuse the research data, the data will be sent to them within one working week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Yalfani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Mostafa Ahmadi Roshan Street</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>38695-65178</zip>
        <telephone>+98 81 3140 0000</telephone>
        <email>yalfani@basu.ac.ir</email>
        <affiliation>Bu Ali Sina University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Yalfani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Mostafa Ahmadi Roshan Street</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>38695-65178</zip>
        <telephone>+98 81 3140 0000</telephone>
        <email>yalfani@basu.ac.ir</email>
        <affiliation>Bu Ali Sina University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>At least three months of pain.
Age range: 40–60 years.
Normal body mass index (BMI).
Pain score greater than 4.</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>60 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>History of injury to the trunk and lower limbs within the past year
Surgery on the lower limbs or back
Spinal inflammation
Spinal fracture
Tumor in the lower back region
Back pain of non-mechanical origin
Having neurological, cardiovascular, or mental health conditions (severe mental disorders and depression)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: The combined intervention (dynamic neuromuscular stabilization exercises integrated with neurofeedback) will be conducted over eight consecutive weeks, consisting of three sessions per week. Each session will last 75 to 80 minutes (comprising 45–50 minutes of dynamic neuromuscular stabilization exercises and 30 minutes of neurofeedback). The dynamic neuromuscular stabilization exercises include diaphragmatic breathing, the 90/90 supine position, prone positioning, rolling, side-sitting, oblique sitting, tripod positioning, kneeling, squatting, and rising to a standing position. Neurofeedback training will be conducted following dynamic neuromuscular stabilization exercises, utilizing an 8-channel ProComp Infiniti system paired with BioGraph software. Drawing upon established protocols for chronic pain, the neurofeedback protocol will focus on increasing the power of alpha waves (8–13 Hz) while suppressing beta (15–20 Hz) and theta (4–7 Hz) wave activity at the Cz site (the central region of the brain). The Cz site was selected due to its proximity to the sensorimotor cortex—an area that plays a vital role in postural control and pain processing.</i_keyword>
      <i_keyword>Second Intervention group: The combined training program—consisting of dynamic neuromuscular stabilization exercises integrated with cognitive-functional exercises—will be conducted over eight consecutive weeks. This will involve three sessions per week, with each session comprising approximately 45 to 50 minutes of dynamic neuromuscular stabilization exercises, alongside a total of eighteen sessions (over the same eight-week period) of cognitive-functional exercises, each lasting 60 minutes. The dynamic neuromuscular stabilization exercises include diaphragmatic breathing, the 90/90 supine position, prone positioning, rolling initiation, side-sitting, oblique sitting, the tripod position, kneeling, squatting, and rising to a standing position. Cognitive-functional exercise sessions will be conducted on an individual basis in a quiet room. This protocol consists of three main components. The cognitive component focuses on identifying the primary factors contributing to pain—as determined during assessments—including the multidimensional nature of chronic pain, as well as the individual’s beliefs, emotions, and behaviors (e.g., movement patterns and lifestyle) that may exacerbate a "domino effect" of pain and disability. Patients will be educated on the biopsychosocial model of pain, and unhelpful beliefs will be addressed through cognitive restructuring. Functional Component: This component includes specific functional exercises designed to normalize movements and postures that are maladaptive or provocative. Patients are gradually exposed to activities they fear or avoid (controlled exposure), ensuring they feel secure while engaging in painful activities or resting their bodies. Lifestyle Component: This component integrates functional activities into daily living tasks, such as bending, sitting, standing, and lying down. Gradual exposure to everyday activities, combined with fear-reduction strategies, is implemented to foster long-term behavioral change.</i_keyword>
      <i_keyword>Control group: At the beginning of the study, all assessments will be administered to the individuals in the control group. These participants will not take part in any rehabilitation interventions; instead, they will continue with their normal, routine lives and daily activities throughout the 8-week period. Following these 8 weeks, a post-test will be conducted.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Pre-test and post-test refer to the time before the start of the first training session and one day after the conclusion of the final training session. Method of measurement: Visual Analog Scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Psychological indicators (functional disability – ​​kinesiophobia), plantar pressure variables, brain electrical activity patterns, and lumbar muscle strength. Timepoint: Pre-test and post-test. Method of measurement: Assessment of psychological and physiological indicators: The Oswestry questionnaire will be used to measure functional disability, and the TEMPA questionnaire will be employed to assess kinesiophobia. Furthermore, a foot pressure measurement system will be used to evaluate plantar pressure variables, an electroencephalography (EEG) device will be utilized to assess patterns of electrical brain activity, and a handheld dynamometer will be used to evaluate the strength of the lower back muscles.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Research Deputy of Bu-Ali Sina University, Hamedan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-09-13</approval_date>
        <contact_name>Research Ethics Committees of Bu Ali Sina University-Hamedan</contact_name>
        <contact_address>Shahid Mostafa Ahmadi Roshan Street Hamedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
